Skip to main content

Progastrin-releasing peptide: stability in plasma/serum and upper reference limit.

Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E

Publication: Tumour Biol (2008) • Vol 29 • Page 204-10PMID: 18667845View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient characteristics, anticoagulant, tube type, storage, and protease inhibitors on the stability progastrin releasing peptide (ProGRP) measured by an immunofluorometric assay (IFMA), in plasma and serum, from healthy individuals and patients with small cell lung cancer (SCLC).

Conclusion

Serum, EDTA- and lithium heparin-plasma levels of ProGRP were stable at -30 degrees C for 4 weeks and through 3 freeze-thaw cycles, but were affected by storage at room temperature or 4 degrees C. The effects of storage of serum at 4 degrees C could be partially attenuated by the addition of aprotinin, leupeptin or EDTA-Na2. High ProGRP levels in healthy individuals were associated with increasing age, increasing creatinine concentrations, decreasing body mass index (BMI), being female, and smoking, but not alcohol consumption or physical activity. The authors report that time of biospecimen collection relative to food consumption had no effects on ProGRP levels, and levels in plain serum tubes and serum separator tubes (SST) were also similar.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient characteristics, anticoagulant, tube type, storage, and protease inhibitors on the stability ProGRP measured by IFMA, in plasma and serum, from healthy individuals and patients with SCLC. The effects of acquisition and storage were investigated in 2-3 specimens, but the effects of preacquisition variables were investigated using 806 specimens.

Summary of Findings

Storage of serum or lithium heparin-plasma from 3 patients with SCLC, at room temperature, for 5 days resulted in decreased ProGRP levels, but storage of EDTA-plasma from 2 of the same 3 patients resulted in increasing ProGRP levels. In contrast, ProGRP levels remained relatively stable when plasma (EDTA or lithium heparin) and serum from 2-3 patients with SCLC were stored at 4 degrees C for up to 3 days and at -30 degrees C for the entire 4 weeks. When lithium heparin-plasma, EDTA-plasma, or serum from 2 healthy individuals were stored at 4 degrees C for 3 days, changes in ProGRP levels of up to 19%, 23% and 16% were observed, respectively. The authors report no effect of 3 freeze-thaw cycles on the levels of ProGRP in lithium heparin-plasma, EDTA-plasma, or serum from a single healthy individual and one patient with SCLC. Pefabloc completely stabilized exogenous ProGRP and partially stabilized endogenous ProGRP levels in serum stored at 4 degrees C for up to 2 weeks. Aprotinin, leupeptin and EDTA-Na2 partially stabilized ProGRP levels (exogenous and endogenous) in serum, but pepstatin and E64 did not improve stability of ProGRP during storage of serum at 4 degrees C. The authors report that time of collection, with respect to food consumption, had no effects on ProGRP levels, and levels in plain serum tubes and SST were also similar. High ProGRP levels in healthy individuals were associated with increasing age, increasing creatinine concentrations, decreasing BMI, being female, and smoking, but not alcohol consumption or physical activity.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)FrozenOther Preservative
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    ProteinImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    100-109 umol/L creatinine
    110-119 umol/L creatinine
    50-59 umol/L creatinine
    60-69 umol/L creatinine
    70-79 umol/L creatinine
    80-89 umol/L creatinine
    90-99 umol/L creatinine
    <49 umol/L creatinine
    >120 umol/L creatinine
    PreaquisitionDiagnosis/ patient condition
    Normal
    Small cell lung cancer
    PreaquisitionOther drugs
    0 cigarettes/day
    0 units alcohol
    1-21 units alcohol
    1-5 cigarettes/day
    >21 units alcohol
    >5 cigarettes/day
    PreaquisitionPatient age
    18-29 years
    30-39 year
    40-49 years
    50-59 years
    60-69 years
    70-79 years
    80-86 years
    PreaquisitionPatient body mass index
    20-24.9
    25-29.9
    <19.9
    >30
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin
    None
    Biospecimen AcquisitionTime of biospecimen collection
    1 PM (after eating)
    10 AM (fasting)
    11 AM (before eating)
    3:45 (before eating)
    Biospecimen AcquisitionType of collection container/solution
    Plain serum tube
    SST
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)
    Refrigeration
    StorageFreeze/thaw cycling
    0 cycles
    1 cycle
    2 cycles
    3 cycles
    StorageStorage duration
    0 days
    1 day
    1 week
    2 weeks
    3 days
    3 weeks
    4 days
    4 weeks
    5 days
    StorageStorage temperature
    -30 degrees C
    4 degrees C
    Room temperature
    Analyte Extraction and PurificationProtease inhibitor
    Aprotinin
    E-64
    Leupeptin
    Pefabloc
    Pepstatin
    Sodium EDTA